Vessey Rupert
SEC CIK 1677618 · EDGAR
BoughtSold
Most active insiders at TECH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Herr Amy E. | Dir | — | $437.2K |
| 2 | Crouse Steven C. | Pres - Diag, Spatial Bi | — | — |
| 3 | Bohnen Shane | SVP - GC | — | — |
| 4 | McManus Matthew | Pres - Diag, Spatial Bio | — | — |
| 5 | Geist William | Pres, PROTEIN SCIENCES | — | — |
| 6 | Klimovsky Judith V. | Dir | — | — |
| 7 | Kelderman Kim | CEO, Dir | — | — |
| 8 | Seth Alpna | Dir | — | — |
| 9 | Vessey Rupert | Dir | — | — |
| 10 | Hippel James | CFO | — | — |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-03 | 2025-10-30 | TECH | Bio-Techne | Vessey Rupert | Dir | A - Grant | $0.00 | +1,640 | 11.0K | +18% | $0 |
| D | 2024-10-28 | 2024-10-24 | TECH | Bio-Techne | VESSEY RUPERT | Dir | A - Grant | $0.00 | +1,462 | 9,347 | +19% | $0 |
| D | 2023-10-30 | 2023-10-26 | TECH | Bio-Techne | VESSEY RUPERT | Dir | A - Grant | $0.00 | +1,625 | 7,885 | +26% | $0 |
| 2023-05-04 | 2023-05-03 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Pres, Research | S - Sale | $67.06 | -50.4K | 47.8K | -51% | -$3.38M | |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Pres, Research | J - Other | $0.00 | +8,326 | 123.7K | +7% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Pres, Research | M - OptEx | $0.00 | +66.9K | 118.3K | +130% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Pres, Research | F - Tax | $65.71 | -38.5K | 73.7K | -34% | -$2.53M |
| D | 2022-12-06 | 2022-12-02 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $81.13 | -4,498 | 61.4K | -7% | -$364.9K |
| D | 2022-12-06 | 2022-12-02 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +8,792 | 65.9K | +15% | $0 |
| DM | 2022-11-09 | 2022-11-07 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $58.31 | +52.6K | 77.5K | +211% | +$3.07M |
| D | 2022-11-09 | 2022-11-07 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | S - Sale+OE | $78.88 | -45.9K | 57.1K | -45% | -$3.62M |
| D | 2022-10-31 | 2022-10-27 | TECH | Bio-Techne | VESSEY RUPERT | Dir | A - Grant | $0.00 | +338 | 1,565 | +28% | $0 |
| DM | 2022-03-18 | 2022-03-16 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $57.00 | +47.3K | 72.9K | +185% | +$2.70M |
| DM | 2022-03-18 | 2022-03-16 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | S - Sale+OE | $69.25 | -74.6K | 46.3K | -62% | -$5.16M |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | J - Other | $0.00 | +1,859 | 82.1K | +2% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +15.2K | 81.2K | +23% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $68.42 | -8,751 | 77.6K | -10% | -$598.7K |
| D | 2022-03-03 | 2022-03-01 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +23.4K | 79.6K | +42% | $0 |
| D | 2022-03-03 | 2022-03-01 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $68.63 | -10.3K | 69.3K | -13% | -$707.1K |
| D | 2022-02-08 | 2022-02-04 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +3,593 | 57.5K | +7% | $0 |
| D | 2022-02-08 | 2022-02-04 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $64.99 | -1,312 | 56.2K | -2% | -$85.3K |
| D | 2022-01-04 | 2021-12-31 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $62.35 | -23.0K | 54.0K | -30% | -$1.44M |
| D | 2022-01-04 | 2021-12-31 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +45.0K | 77.0K | +141% | $0 |
| M | 2021-12-17 | 2021-12-16 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | S - Sale | $61.99 | -19.3K | 32.0K | -38% | -$1.20M |
| D | 2021-12-06 | 2021-12-02 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +8,792 | 55.8K | +19% | $0 |
| D | 2021-12-06 | 2021-12-02 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $55.41 | -4,498 | 51.3K | -8% | -$249.2K |
| D | 2021-11-01 | 2021-10-28 | TECH | Bio-Techne | VESSEY RUPERT | Dir | A - Grant | $0.00 | +194 | 1,227 | +19% | $0 |
| DM | 2021-08-03 | 2021-07-30 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $58.49 | +151.0K | 42.5K | New | +$8.83M |
| DM | 2021-08-03 | 2021-07-30 | BMY | Bristol Myers Squibb | VESSEY RUPERT | EVP, Research, Early Dev | S - Sale+OE | $68.07 | -158.4K | 36.6K | -81% | -$10.78M |
Purchase Sale Sale after option exercise All abbreviations